Mary Caffrey

One-third of seniors say a family member coordinates their care, but another one-third say no one does.

The pharmaceutical leader's move comes after the American Diabetes Association asked Congress to investigate rising insulin prices.

The study found that peer support helped even if the person providing help did not have diabetes but simply had knowledge on the disease.

The study found that periodic interruptions over the course of the day were better for improving levels of insulin resistance than a single burst of exercise.

The group that represents 5000 hospitals outlined a policy agenda that calls for regulatory reform but also seeks some certainty that patients who gained coverage under the Affordable Care Act will be able to retain it in the future.

Prescription drug spending didn't rise as much as it did in 2014, but it still outpaced all other categories.

Researchers considered finding a diabetes drug that also produced a cardiovascular benefit to be a "holy grail."

The phenomenon of "yo-yo" dieting has health consequences and frustrates dieters themselves. Studies show each round of weight loss and weight regain produces harsher metabolic effects.

The physicians said the American Medical Association abandoned a core mission of protecting patients by endorsing a nominee who wants to roll back Medicaid expansion and privatize Medicare.

The study found that avoiding 3 key risk factors-diabetes, obesity, and hypertension-by age 45, greatly increased the likelihood of avoiding heart failure through the end of life.

The study found young adults had the lowest device uptake, as well as highest distress levels and the highest A1C.

In New Jersey, a group of business and labor leaders-along with the state's largest health plan-decided it was time for the term "patient-centered" to be understood by a key constituency: patients themselves.

Early results published Tuesday were first presented this summer at the meeting of the American Diabetes Association.

Awareness of Medicaid eligibility rules meant that in 2014 alone, more than 2 million people enrolled for benefits who belonged in the program but for some reason had never signed up.

The statement calls for delivery behavioral health services through a collaborative model when possible, both to share electronic health data and offer convenience and continuity for patients.

While smoking has long been known to aggravate diabetes, the new study shows just how deadly the habit is for those with the chronic condition.

Some estimates put the market for insulin and GLP-1 combination therapy at $1 billion.

Scientists compared genomes of more than 20,000 people with schizophrenia and 20,000 without the mental disorder to uncover the variants associated with the disease.

The matchstick-size pump has been heralded as a game changer in addressing the biggest problem in diabetes care: medication adherence.

The authors leave open the possibility that current reporting systems are not catching the impact of all medication errors. A different study earlier this year found that medical errors, including those that involve medication, caused so many deaths that the CDC should change its reporting methods to account for them.

The meeting in New Orleans featured surprising clinical findings and some attention-grabbing consumer news.

Earlier this month, 2 members of Congress called for the Justice Department and the Federal Trade Commission to examine whether the major insulin manufacturers are coordinating on prices.

Public health officials scrutinize obesity rates among young children as an indicator of how efforts to combat the epidemic are faring overall.

The report did not break out the number of overdose deaths, but prior information said that 2014 had the most overdose deaths on record.

Studies of the effect of diet soda on diabetes and obesity have produced mixed results.

A study inspired by a patient who could not afford his heart medication shows that there was no pattern to price variability for a common regimen to treat heart failure, which could contribute to poor adherence.

For some time, cardiologists have wondered whether there was anything to be gained by pushing LDL or "bad" cholesterol to very low levels.

A study of a pair of large databases shows a strong link between obesity and heart failure.

The study finds one-quarter of the patients stop taking anticoagulants within 3 months and nearly three-quarters have stopped after 2.25 years.

The results point to the need for more study on the effects of long-duration blood pressure treatment to prevent cognitive decline, especially in the highest risk patients.